Oculus Innovative Sciences, Inc. (NASDAQ:OCLS)’s innovative Microcyn Technology


Dallas, Texas 09/09/2013 (Financialstrend) – Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) stock dropped by 2.14% in Friday’s trading session. The opening price of the shares was $2.76 which touched an intraday high of $2.80 and dipped to close at $2.75. More than 0.249 million shares were traded in on Friday while the average volume of shares traded over 30 days was 0.532. The company has a market cap of $18.22 million.

The company

OCLS is a commercial health care company. It is involved in designing, producing and marketing safe devices, drugs and nutritional products. The company primarily focuses on Microcyn Technology, its specialized technology platform. This particular technology is based on electrically-charged small oxychlorine molecules. These molecules are designed so that they will target a variety of organisms that cause pathogens or diseases.

The treatments

These include spores, fungi, viruses as well as different antibiotic resistant bacteria strains. The bacterial strains that it resists are vancomycin-resistant Enterococcus, Staphylococcus aureus and Clostridium difficile.Many Microcyn Technology tissue-care products are designed for the treatment of various infections. They reduce the need for antibiotics and enhance healing. Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) has 2 primary subsidiaries- Oculus Innovative Sciences Netherlands, B.V and Oculus Technologies of Mexico, S.A. de C.V

About the Microcyn technology

Microcyn is essentially a solution of different oxychlorine compounds. Amongst other things, these interact with and then inactivate the surface proteins on the membrane and walls of microorganism cells. These proteins have various functions. They play a role in waste and nutrient transport, cell communication and many other functions that are required for the viability of cells.

Once Microcyn has surrounded any single-cell microorganisms, it goes ahead and damages these proteins. Eventually, the cell membrane ruptures and leads to cell death. OCLS continues to study all the exact mechanisms via which structural and protein components of membranes and bacterial cell walls and the protein shell that surrounds any virus, are affected by the Microcyn treatment.